Tanovea-CA1 (rabacfosadine for injection)

Hazard statements (CLP)

H341, H360

Code

Statements

H341

Suspected of causing genetic defects

SECTION 2: Hazards identification

GHS US classification Classification of the substance or mixture GHS-US classification Germ cell mutagenicity, H341 Suspected of causing genetic defects Category 2 Reproductive toxicity, H360 May damage fertility or the unborn child Category 1B Full text of H statements see section 16

2.2 Label elements

GHS-US labelling

Hazard pictograms

GHS08

Signal word

Danger

Hazard statements

H341 - Suspected of causing genetic defects H360 - May damage fertility or the unborn child

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear eye protection, protective clothing, protective gloves P308+P313 - If exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation

Other hazards which do not result in classification

No additional information available

Ingredient(s) with unknown acute toxicity

48% of the mixture consists of ingredient(s) of unknown acute toxicity (Oral) 48% of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal) 48% of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Dust/Mist))

2.1 Classification of the substance or mixture

GHS-US classification Germ cell mutagenicity, H341 Suspected of causing genetic defects Category 2 Reproductive toxicity, H360 May damage fertility or the unborn child Category 1B Full text of H statements : see section 16